To further expand mRNA and ADC pipelines
Reaccelerate on strong pipeline in FY23E
境内恢复领先同行，Pipeline环比明显提升
连续获批版号，强化2023年Pipeline确定性
2022H1收入+46.83%，归母净利+41.21%，批产产品加速放量，新型号Pipeline持续拓展
Clinical development of core pipeline products continues
Rosy pipeline ahead, non-game segments improving
（中英文）美国如何拆除北溪管道How America Took Out The Nord Stream Pipeline
EVIF Project Pipeline - August 2024
定价机制改革或落地歼击机龙头起航，Pipeline提升业绩望进一步释放
公众号
小程序
社群
公众号小程序社群